Advanced search
Publication Cover
Substance Use & Misuse Volume 55, 2020 - Issue 7
Submit an article Journal homepage
2,397
Views
54
CrossRef citations to date
0
Altmetric
Original Articles

CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults

Meghann WheelerDepartment of Public Health, University of North Florida, Jacksonville, Florida, USA; Correspondence[email protected] [email protected]
,
Julie Williams MertenDepartment of Public Health, University of North Florida, Jacksonville, Florida, USA;
,
Benjamin T GordonCollege of Health and Human Performance, University of Florida, Gainesville, Florida, USA;
&
Hanadi HamadiDepartment of Health Administration, University of North Florida, Jacksonville, Florida, USAORCID Iconhttp://orcid.org/0000-0001-9050-7267
ORCID Icon
Pages 1138-1145 | Published online: 24 Feb 2020

Citations (54)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Patrik Roser, Benedikt Habermeyer, Norbert Scherbaum & Barbara Lay. (2023) Cannabidiol use among patients with substance use disorders. Journal of Substance Use 28:6, pages 982-988.
Read now
Jan M Schilling, Chloe G Hughes, Mark S Wallace, Michelle Sexton, Miroslav Backonja & Tobias Moeller-Bertram. (2021) Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes. Journal of Pain Research 14, pages 1241-1250.
Read now
P. S. Cogan. (2020) Reality and Legality: Disentangling What Is Actual from What Is Tolerated in Comparisons of Hemp Extracts with Pure CBD. Journal of Dietary Supplements 17:5, pages 527-542.
Read now
Julie Williams Merten, Benjamin T. Gordon, Jessica L. King & Calista Pappas. (2020) Cannabidiol (CBD): Perspectives from Pinterest. Substance Use & Misuse 55:13, pages 2213-2220.
Read now

Articles from other publishers (50)

Carla J. Berg, Gillian L. SchauerPatricia Cavazos-RehgKatelyn F. RommYan WangChristina N. WysotaZongshuan DuanLisa Henriksen. (2023) Cannabidiol Marketing Strategies in the United States: An Analysis of Three Prominent Companies. Cannabis and Cannabinoid Research 8:6, pages 1150-1160.
Crossref
Christina N. WysotaLisa HenriksenKatelyn F. RommZongshuan DuanYan WangJidong HuangCarla J. Berg. (2023) Cannabidiol Knowledge, Perceptions, and Use Among Young Adults in 6 U.S. Metropolitan Areas. Cannabis and Cannabinoid Research 8:6, pages 1140-1149.
Crossref
Johanna Geppert, Julika Lietzow, Stefanie Hessel-Pras, Fabian Kirsch, Bernd Schäfer & Benjamin Sachse. (2023) Usage and health perception of cannabidiol-containing products among the population in Germany: a descriptive study conducted in 2020 and 2021. BMC Public Health 23:1.
Crossref
Tangui Barré, Damien Testa, Melina Santos, Fabienne Marcellin, Perrine Roux, Patrizia Carrieri, Lise Radoszycki & Camelia Protopopescu. (2023) Symptom severity is a major determinant of cannabis‐based products use among people with multiple sclerosis. Journal of Clinical Nursing 32:17-18, pages 6460-6473.
Crossref
Hongying Daisy Dai, Roma Subramanian, Avina Mahroke & Ming Wang. (2023) Prevalence and Factors Associated With Vaping Cannabidiol Among US Adolescents. JAMA Network Open 6:8, pages e2329167.
Crossref
Eric Fordjour, Charles F. Manful, Albert A. Sey, Rabia Javed, Thu Huong Pham, Raymond Thomas & Mumtaz Cheema. (2023) Cannabis: a multifaceted plant with endless potentials. Frontiers in Pharmacology 14.
Crossref
G. Shaw, F. Fehr & P. Tsigaris. (2023) Barriers for access to cannabidiol as a treatment option for children with neuro-diverse disabilities: A qualitative key informants method. Ethics, Medicine and Public Health 28, pages 100904.
Crossref
Shelby Hopkins, Tel Kelley, Rachel Roller, Robert S. Thompson, Dorothy B. Colagiovanni, Kris Chupka & Monika Fleshner. (2023) Oral CBD-rich hemp extract modulates sterile inflammation in female and male rats. Frontiers in Physiology 14.
Crossref
Charlotte A. Love, Hye-Young H. Kim, Keri A. Tallman, Phillip W. Clapp, Ned A. Porter & Ilona Jaspers. (2023) Vaping Induced Cannabidiol (CBD) Oxidation Product CBD Quinone Forms Protein Adducts with KEAP1 and Activates KEAP1-Nrf2 Genes. Chemical Research in Toxicology 36:4, pages 565-569.
Crossref
Hailey N. Lynch, Claire Chaz Authement, Autumn Maczko, Miranda Parker, Kaylan Beaty & Anuradha Liyana Pathiranage. (2023) Gas Chromatography–Mass Spectrometry Analysis of Cannabis: Undergraduate Organic Chemistry Laboratory Exercise. Journal of Chemical Education 100:3, pages 1303-1312.
Crossref
Yongjie Li, Xiangyu Yan, Zekun Wang, Mingchang Ma, Bo Zhang & Zhongwei Jia. (2023) Comparison of the Users’ Attitudes Toward Cannabidiol on Social Media Platforms: Topic Modeling Study. JMIR Public Health and Surveillance 9, pages e34132.
Crossref
Marlize Krüger, Tertia van Eeden & Daniso Beswa. (2022) Cannabis sativa Cannabinoids as Functional Ingredients in Snack Foods—Historical and Developmental Aspects. Plants 11:23, pages 3330.
Crossref
Hannah Gardener, Chela Wallin & Jaclyn Bowen. (2022) Heavy metal and phthalate contamination and labeling integrity in a large sample of US commercially available cannabidiol (CBD) products. Science of The Total Environment 851, pages 158110.
Crossref
Christina N Wysota, Daisy Le, Michelle Elise Clausen, Annie Coriolan Ciceron, Caroline Fuss, Breesa Bennett, Katelyn F Romm, Zongshuan Duan & Carla J Berg. (2022) Young adults’ knowledge, perceptions and use of cannabidiol products: a mixed-methods study. Health Education Research 37:6, pages 379-392.
Crossref
Ryan Green, Roukiah Khalil, Shyam S. Mohapatra & Subhra Mohapatra. (2022) Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges. International Journal of Molecular Sciences 23:21, pages 12956.
Crossref
Clémence Casanova, Clémence Ramier, Davide Fortin, Patrizia Carrieri, Julien Mancini & Tangui Barré. (2022) Cannabidiol use and perceptions in France: a national survey. BMC Public Health 22:1.
Crossref
Ayşegül BEŞİR, Nurdan YAZICI BEKTAŞ, Mustafa MORTAŞ & Fehmi YAZICI. (2022) Kenevirde THC ve CBD Faktörlerinin DeğerlendirilmesiEvaluation of THC and CBD Factors in Cannabis. Osmaniye Korkut Ata Üniversitesi Fen Bilimleri Enstitüsü Dergisi 5:2, pages 1092-1104.
Crossref
Małgorzata Morawska-Tota, Łukasz Tota & Joanna Tkaczewska. (2022) Influence of 5-Week Snack Supplementation with the Addition of Gelatin Hydrolysates from Carp Skins on Pro-Oxidative and Antioxidant Balance Disturbances (TOS, TAS) in a Group of Athletes. Antioxidants 11:7, pages 1314.
Crossref
Melissa B. Harrell, Stephanie L. Clendennen, Aslesha Sumbe, Kathleen R. Case, Dale S. Mantey & Sunaina Swan. (2022) Cannabis Vaping Among Youth and Young Adults: a Scoping Review. Current Addiction Reports 9:3, pages 217-234.
Crossref
Michael S. Dunbar, Rachana Seelam, Joan S. Tucker, Caislin L. Firth, Eric R. Pedersen, David J. Klein, Anthony Rodriguez & Elizabeth J. D'Amico. (2022) Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults. Addictive Behaviors 126, pages 107185.
Crossref
Alex R. Mills, Molly A. Nichols & Elizabeth Davenport. (2022) Chronic pain and medical cannabis: Narrative review and practice considerations in persons living with HIV. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 5:3, pages 342-353.
Crossref
Hannah Dräger, Ines Barthlott, Patricia Golombek, Stephan G. Walch & Dirk W. Lachenmeier. (2022) Time Trends of Tetrahydrocannabinol (THC) in a 2008–2021 German National Survey of Hemp Food Products. Foods 11:3, pages 486.
Crossref
Owen S. Miller, Edmund J. ElderJr.Jr., Karen J. Jones & Barry E. Gidal. (2022) Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners. Epilepsy & Behavior 127, pages 108514.
Crossref
Avijeet S. Chopra, Ronan Lordan, Olaf K. Horbańczuk, Atanas G. Atanasov, Ishveen Chopra, Jarosław O. Horbańczuk, Artur Jóźwik, Linfang Huang, Vasil Pirgozliev, Maciej Banach, Maurizio Battino & Nicolas Arkells. (2022) The current use and evolving landscape of nutraceuticals. Pharmacological Research 175, pages 106001.
Crossref
Kevin F. Boehnke, Joel J. Gagnier, Lynne Matallana & David A. Williams. (2022) Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia. The Journal of Pain 23:1, pages 45-54.
Crossref
Hannah Lacasse & Jane Kolodinsky. 2022. Industrial Hemp. Industrial Hemp 367 381 .
Henri Blandinières & Stefano Amaducci. 2022. Cannabis/Hemp for Sustainable Agriculture and Materials. Cannabis/Hemp for Sustainable Agriculture and Materials 89 125 .
Jeremy Henson, Luis Vitetta, Michelle Quezada & Sean Hall. (2021) Enhancing Endocannabinoid Control of Stress with Cannabidiol. Journal of Clinical Medicine 10:24, pages 5852.
Crossref
Julie Moltke & Chandni Hindocha. (2021) Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems. Journal of Cannabis Research 3:1.
Crossref
Christopher J Failing, Kevin F. Boehnke & Meredith Riebschleger. (2021) Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis. Pediatric Rheumatology 19:1.
Crossref
Xiaoyan Chen, Hua Deng, Janai A. Heise, David P. Puthoff, Nabeel Bou-Abboud, Hongtao Yu & Jiangnan Peng. (2021) Contents of Cannabinoids in Hemp Varieties Grown in Maryland. ACS Omega 6:47, pages 32186-32197.
Crossref
Nicholas C. Glodosky, Carrie Cuttler & Ryan J. McLaughlin. (2021) A review of the effects of acute and chronic cannabinoid exposure on the stress response. Frontiers in Neuroendocrinology 63, pages 100945.
Crossref
Brandon A. Berger, Uwe Stolz, Jonathan Colvin & Edward J. Otten. (2021) Epidemiology of cannabidiol related cases reported in the National Poison Data System – 2019-2020. The American Journal of Emergency Medicine 48, pages 218-223.
Crossref
Alexandra M. WardJon O. Ebbert. (2021) Carbonyl Compounds in Mainstream Smoke of Hemp Cigarettes. Cannabis and Cannabinoid Research 6:4, pages 349-357.
Crossref
Keeley Dunn, Amelia Taylor & Sophie Turfus. (2021) A review of cannabidiol‐containing electronic liquids—Current regulations and labelling accuracy. Drug Testing and Analysis 13:8, pages 1490-1498.
Crossref
Israel T. Agaku, Catherine O. Egbe & Olalekan A. Ayo-Yusuf. (2021) Circumvention of COVID-19-related restrictions on tobacco sales by the e-cigarette industry in South Africa and comparative analyses of heated tobacco product vs combustible cigarette volume sales during 2018–2020. Preventive Medicine 148, pages 106526.
Crossref
Ines Barthlott, Andreas Scharinger, Patricia Golombek, Thomas Kuballa & Dirk Lachenmeier. (2021) A Quantitative 1H NMR Method for Screening Cannabinoids in CBD Oils. Toxics 9:6, pages 136.
Crossref
Ekaterina V. Fedorova, Carolyn F. Wong, Janna Ataiants, Ellen Iverson, Bridgid M. Conn & Stephen E. Lankenau. (2021) Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles. Drug and Alcohol Dependence 221, pages 108648.
Crossref
Magdalena Leszko & Senthil Meenrajan. (2021) Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer’s disease. Complementary Therapies in Medicine 57, pages 102660.
Crossref
Saoirse E. O'SullivanCarl W. StevensonSteven R. Laviolette. (2021) Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?. Cannabis and Cannabinoid Research 6:1, pages 7-18.
Crossref
Joseph R. Vilches, Mackenzie B. Taylor & Francesca M. Filbey. (2021) A Multiple Correspondence Analysis of Patterns of CBD Use in Hemp and Marijuana Users. Frontiers in Psychiatry 11.
Crossref
Theresa Schmidt, Jacqueline Stommel, Tim Kohlmann, Annemarie E. Kramell & René Csuk. (2021) Separating the true from the false: A rapid HPTLC-ESI-MS method for the determination of cannabinoids in different oils. Results in Chemistry 3, pages 100234.
Crossref
Maria Fernanda Arboleda & Erin Prosk. 2021. Cannabinoids and Pain. Cannabinoids and Pain 135 143 .
Kristijonas Puteikis & Rūta Mameniškienė. (2020) Use of cannabis and its products among patients in a tertiary epilepsy center: A cross-sectional survey. Epilepsy & Behavior 111, pages 107214.
Crossref
Dennis J. Sholler, Lauren Schoene & Tory R. Spindle. (2020) Therapeutic Efficacy of Cannabidiol (CBD): a Review of the Evidence From Clinical Trials and Human Laboratory Studies. Current Addiction Reports 7:3, pages 405-412.
Crossref
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, Frauke Herbi, Yvonne Zerbe, Verena Bock, Tabata Rajcic de Rezende, Stephan G. Walch & Constanze Sproll. (2023) Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?. F1000Research 8, pages 1394.
Crossref
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, Frauke Herbi, Yvonne Zerbe, Verena Bock, Tabata Rajcic de Rezende, Stephan G. Walch & Constanze Sproll. (2022) Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?. F1000Research 8, pages 1394.
Crossref
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, Frauke Herbi, Yvonne Zerbe, Verena Bock, Tabata Rajcic de Rezende, Stephan G. Walch & Constanze Sproll. (2021) Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?. F1000Research 8, pages 1394.
Crossref
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, Frauke Herbi, Yvonne Zerbe, Verena Bock, Tabata Rajcic de Rezende, Stephan G. Walch & Constanze Sproll. (2020) Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?. F1000Research 8, pages 1394.
Crossref
Hannah Gardener, Chela Wallin & Jaclyn Bowen. (2022) Heavy Metal and Phthalate Contamination and Labeling Integrity in a Large Sample of Us Commercially Available Cannabinoid (Cbd) Products. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.